IRIS
ROSELLI, MARIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 57.873
EU - Europa 4.365
AS - Asia 2.373
Continente sconosciuto - Info sul continente non disponibili 25
SA - Sud America 20
OC - Oceania 10
AF - Africa 5
Totale 64.671
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 57.849
SG - Singapore 1.212
UA - Ucraina 761
DE - Germania 756
CN - Cina 669
IT - Italia 653
IE - Irlanda 645
RU - Federazione Russa 374
KR - Corea 270
FR - Francia 243
GB - Regno Unito 222
PL - Polonia 216
FI - Finlandia 185
SE - Svezia 171
ID - Indonesia 67
NL - Olanda 36
JP - Giappone 35
BE - Belgio 29
VN - Vietnam 24
IN - India 22
CA - Canada 21
CZ - Repubblica Ceca 19
EU - Europa 19
TW - Taiwan 14
ES - Italia 10
HK - Hong Kong 10
RO - Romania 10
AU - Australia 9
AT - Austria 8
BR - Brasile 8
CH - Svizzera 8
KG - Kirghizistan 7
CL - Cile 6
PH - Filippine 6
SA - Arabia Saudita 6
TH - Thailandia 5
TR - Turchia 5
A2 - ???statistics.table.value.countryCode.A2??? 4
AE - Emirati Arabi Uniti 4
GR - Grecia 4
NO - Norvegia 4
EG - Egitto 3
IR - Iran 3
LT - Lituania 3
A1 - Anonimo 2
AM - Armenia 2
BD - Bangladesh 2
EC - Ecuador 2
HR - Croazia 2
KW - Kuwait 2
MN - Mongolia 2
PE - Perù 2
PT - Portogallo 2
ZA - Sudafrica 2
AR - Argentina 1
BG - Bulgaria 1
BO - Bolivia 1
BZ - Belize 1
CR - Costa Rica 1
EE - Estonia 1
HU - Ungheria 1
IQ - Iraq 1
JO - Giordania 1
KZ - Kazakistan 1
LU - Lussemburgo 1
MX - Messico 1
MY - Malesia 1
NZ - Nuova Zelanda 1
PK - Pakistan 1
UZ - Uzbekistan 1
Totale 64.671
Salva come PNG Salva come JPEG
Città #
Woodbridge 16.968
Wilmington 15.628
Houston 14.960
Fairfield 1.700
Singapore 1.065
Ann Arbor 1.039
Chandler 866
Ashburn 829
Seattle 696
Jacksonville 682
Cambridge 638
Dublin 574
Medford 432
Dearborn 296
Rome 275
Santa Clara 270
Beijing 247
New York 218
Kraków 215
Lawrence 201
San Diego 141
Menlo Park 128
Zhengzhou 94
Moscow 88
Engelhard 73
Milan 62
Jakarta 57
Mülheim 56
London 50
Saint Petersburg 49
Falls Church 46
Boardman 42
Nanjing 39
Norwalk 37
Hefei 34
Redwood City 34
Shanghai 34
Brussels 29
Helsinki 28
Mountain View 26
Detroit 23
Guangzhou 23
Kunming 23
University Park 23
Phoenix 22
Verona 21
Hangzhou 20
Palo Alto 20
Los Angeles 17
Seoul 17
Council Bluffs 16
Dong Ket 16
Nürnberg 16
Brno 14
Nanchang 14
Taipei 14
Toronto 14
Munich 12
Nuremberg 12
Creede 11
Chicago 10
Monte Vista 10
Turin 10
Chengdu 9
Lappeenranta 9
Tokyo 9
Bandung 8
Hounslow 8
Indiana 8
Jinan 8
San Jose 8
Hebei 7
Miami 7
Pune 7
Redmond 7
Shenyang 7
Wuhan 7
Amsterdam 6
Bologna 6
Buffalo 6
Colle di Val d'Elsa 6
Columbus 6
Del Norte 6
Hanoi 6
Naples 6
Central District 5
Changsha 5
Frankfurt am Main 5
San Francisco 5
San Mateo 5
Vienna 5
Augusta 4
Bangkok 4
Baotou 4
Barcelona 4
Bari 4
Chongqing 4
Colorado Springs 4
Durham 4
Fort Worth 4
Totale 59.547
Salva come PNG Salva come JPEG
Nome #
Role of serum and glucocorticoid-inducible kinase (SGK)-1 in senescence: a novel molecular target against age-related diseases 497
Longterm results after resection of simultaneous and sequential lung and liver metastases from colorectal carcinoma 484
Sex-Genetic Interaction in the Risk for Cerebrovascular Disease 477
Vascular endothelial growth factor (VEGF-A) plasma levels in non-small cell lung cancer: relationship with coagulation and platelet activation markers 464
Pharmacogenomics and pharmacogenetics of thiazolidinediones: Role in diabetes and cardiovascular risk factors 464
Sample PREanalytical Code for labeling of biospecimens: an analysis of specimen labeling protocols 458
Role of CA19.9 in predicting bevacizumab efficacy for metastatic colorectal cancer patients 436
Angiogenesis and hypertension: the dual role of anti-hypertensive and anti-angiogenic therapies 435
Anti-angiogenic drugs, vascular toxicity and thromboembolism in solid cancer 435
Predictive value of high-sensitive D-dimer determination for chemotherapy-associated venous thromboembolism in gastrointestinal cancer patients 434
Impact of endoscopic ultrasound-guided fine-needle aspiration and multidisciplinary approach in the management of abdominal or mediastinal mass 433
Position paper of the Italian Association of Medical Oncology on early palliative care in oncology practice (Simultaneous Care) 432
Aging: an important risk factor in chemotherapy-associated vascular diseases 431
Butyryl-cholinesterase is related to muscle mass and strength. A new biomarker to identify elderly subjects at risk of sarcopenia 429
Pathological classification of DCIS and planning of therapeutic management 428
Ketogenic diet and other dietary intervention strategies in the treatment of cancer 427
Spontaneous immunogenicity of ribosomal P0 protein in patients with benign and malignant breast lesions and delay of mammary tumor growth in P0-vaccinated mice 425
The incidence of hip, forearm, humeral, ankle, and vertebral fragility fractures in Italy: results from a 3-year multicenter study 424
Minimal sentinel node procedure for staging early breast cancer 424
Increased risk of chemotherapy-associated venous thromboembolism in elderly patients with cancer 423
Effects of conventional therapeutic interventions on the number and function of regulatory T cells 422
Brachyury, a driver of the epithelial-mesenchymal transition, is overexpressed in human lung tumors: an opportunity for novel interventions against lung cancer 422
Soluble selectin levels in patients with lung cancer 421
Immune reaction and colorectal cancer: friends or foes? 420
Biological and predictive role of ERCC1 polymorphisms in cancer 420
TNF-α gene promoter polymorphisms and risk of venous thromboembolism in gastrointestinal cancer patients undergoing chemotherapy 416
Type 2 diabetes and breast cancer: The interplay between impaired glucose metabolism and oxidant stress 416
Influence of low-dose beta-interferon on natural killer cell activity in breast cancer patients subjected to chemotherapy 414
Prognostic value of glycated hemoglobin in colorectal cancer 414
Tumor immunotherapy: drug-induced neoantigens (xenogenization) and immune checkpoint inhibitors 414
An international expanded-access programme of everolimus: addressing safety and efficacy in patients with metastatic renal cell carcinoma who progress after initial vascular endothelial growth factor receptor-tyrosine kinase inhibitor therapy 414
Venous thromboembolism risk prediction in ambulatory cancer patients: Clinical significance of neutrophil/lymphocyte ratio and platelet/lymphocyte ratio 413
Prognostic value of carcinoembryonic antigen and vascular endothelial growth factor tumor tissue content in colorectal cancer 412
Clinical models and biochemical predictors of VTE in lung cancer 412
Gender differences in cancer-associated venous thromboembolism 412
Detection of circulating tumor cells is improved by drug-induced antigen up-regulation: preclinical and clinical studies 411
Sentinel lymphadenectomy in cutaneous melanoma 411
Novel high-sensitive D-dimer determination predicts chemotherapy-associated venous thromboembolism in intermediate risk lung cancer patients 411
Oxidant stress as a major determinant of platelet activation in invasive breast cancer 411
RFID as a new ICT tool to monitor specimen life cycle and quality control in a biobank 410
Functional impairment of activated protein C in breast cancer - relationship to survival outcomes 410
Day-surgical management of ductal carcinoma in situ (DCIS)of the breast using wide local excision with sentinel node biopsy 408
Early changes of a novel APC-dependent thrombin generation assay during chemotherapy independently predict venous thromboembolism in cancer patients--a pilot study 407
RISK: A random optimization interactive system based on kernel learning for predicting breast cancer disease progression 407
A phase I/II trial of the safety and clinical activity of a HER2-protein based immunotherapeutic for treating women with HER2-positive metastatic breast cancer 406
Risk assessment for venous thromboembolism in chemotherapy treated ambulatory cancer patients: a machine learning approach 404
Differential expression of a new tumor-associated antigen, TLP, during human colorectal cancer tumorigenesis 402
Obesity and colorectal cancer: role of adipokines in tumor initiation and progression 401
Chemoprevention of colonic cancer: is there a foreseeable future? 400
Adjuvant chemotherapy for stage IB non-small cell lung cancer 400
An activated protein C-dependent thrombin generation assay predicts chemotherapy-associated venous thromboembolism in cancer patients 400
Thromboembolic events in patients treated with anti-angiogenic drugs 399
Rehabilitation in neuro-oncology: a meta-analysis of published data and a mono-institutional experience 399
Efficacy of the combination of cisplatin with either gemcitabine and vinorelbine or gemcitabine and paclitaxel in the treatment of locally advanced or metastatic non-small-cell lung cancer: a phase III randomised trial of the Southern Italy Cooperative Oncology Group (SICOG 0101) 398
Monoclonal antibodies in gastrointestinal cancers 398
Serum sE-selectin levels and carcinoembryonic antigen mRNA-expressing cells in peripheral blood as prognostic factors in colorectal cancer patients 397
Comparative studies between in vitro and in vivo effects of human beta-interferon on natural killer activity and its relevance to immunochemotherapy 397
Cardiac surgery with extracorporeal circulation in cancer patients: risk factors for late survival and cancer-related event-free survival 395
Prognostic value of pre-surgical plasma PAI-1 (plasminogen activator inhibitor-1) levels in breast cancer 395
Pretreatment Insulin Levels as a Prognostic Factor for Breast Cancer Progression 395
Family history of cancer in patients with gastric cancer 392
The value of soluble selectin levels in the management of lung cancer patients 389
Postoperative adjuvant therapy for stage IB non-small-cell lung cancer 388
Prognostic value of vascular endothelial growth factor tumor tissue content of colorectal cancer 385
Prognostic value of soluble P-selectin levels in colorectal cancer 385
Platinum-based compounds and risk for cardiovascular toxicity in the elderly: role of the antioxidants in chemoprevention 385
VEGF and VTE risk in cancer patients-letter 384
VEGF gene promoter polymorphisms and risk of VTE in chemotherapytreated cancer patients 384
Association between increased tumor necrosis factor alpha levels and acquired activated protein C resistance in patients with metastatic colorectal cancer 380
Ensuring Sample Quality for Biomarker Discovery Studies - Use of ICT Tools to Trace Biosample Life-cycle 380
Are there alternative ways to quantify the real benefit of novel agents in oncology? - The 'death pace' 380
Determinants of homocysteine levels in colorectal and breast cancer patients 379
Serum tissue polypeptide specific antigen (TPS): a complementary tumor marker to CA 15-3 in the management of breast cancer 379
Bevacizumab as first-line treatment in HER2-negative advanced breast cancer: Pros and cons 379
Intraoperative radioimmunolocalization of an anti-CEA MAb F(Ab')2 (FO23C5) in CEA serum-negative colorectal cancer patients 378
Chemotherapy enhances vaccine-induced antitumor immunity in melanoma patients 377
null 377
Overexpression of the EMT driver brachyury in breast carcinomas: association with poor prognosis 377
Insulinemia and the risk of breast cancer and its relapse 376
Percutaneous cryoablation and vertebroplasty: a case report 374
In vivo comparison of CHX-DTPA ligand isomers in athymic mice bearing carcinoma xenografts 374
Evaluation of mean platelet volume as a predictive marker for cancer-associated venous thromboembolism during chemotherapy 373
Residual telomerase activity: a marker of cell survival after exposure to gamma radiation in vitro 372
Anti-PD-L1/TGFβR2 (M7824) fusion protein induces immunogenic modulation of human urothelial carcinoma cell lines, rendering them more susceptible to immune-mediated recognition and lysis 371
The Medical Care Continuity (MCC) project. A pilot study of video-assisted home care within the eTEN European Community program. The Italian experience 369
A re-evaluation of carcinoembryonic antigen (CEA) as a serum marker for breast cancer: a prospective longitudinal study 369
[Ductal carcinoma in situ (DCIS): an always present reality; which treatment? Role of sentinel lymph node] 369
The use of B72.3 second generation (CC) monoclonal antibody for the radioimmunolocalization of human carcinoma xenografts 368
Comparative analysis of CA 242 and CA 19-9 serum tumor markers in colorectal cancer patients. A longitudinal evaluation 367
Evaluation of the CA 242 tumor antigen as a potential serum marker for colorectal cancer 365
A prospective observational study to evaluate G-CSF usage in patients with solid tumors receiving myelosuppressive chemotherapy in Italian clinical oncology practice 365
The association of clinical outcome and peripheral T-cell subsets in metastatic colorectal cancer patients receiving first-line FOLFIRI plus bevacizumab therapy 365
Brachyury, a vaccine target, is overexpressed in triple-negative breast cancer 365
Correlation between tumor necrosis factor-alpha and D-dimer levels in non-small cell lung cancer patients 364
Mutational analysis of gastrointestinal stromal tumors (GISTs): procedural approach for diagnostic purposes 364
Neutrophil/lymphocyte ratio helps select metastatic pancreatic cancer patients benefitting from oxaliplatin 364
Baseline physical functioning status of metastatic colorectal cancer patients predicts the overall survival but not the activity of a front-line oxaliplatin-fluoropyrimidine doublet 363
Phase angle as bioelectrical marker to identify elderly patients at risk of sarcopenia 362
Predictive value of high-density lipoprotein (HDL)-cholesterol for cancer-associated venous thromboembolism during chemotherapy 360
Kallikrein-related peptidases targeted therapies in prostate cancer: Perspectives and challenges 360
Totale 40.131
Salva come PNG Salva come JPEG
Categoria #
all - tutte 133.701
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 133.701
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202010.055 0 0 0 0 0 1.906 1.509 1.491 1.507 1.333 1.069 1.240
2020/202110.145 1.056 1.214 1.006 1.250 1.209 1.163 1.387 1.003 223 191 353 90
2021/20222.313 111 241 84 105 98 178 212 181 146 259 166 532
2022/20232.460 266 205 60 275 237 597 207 163 190 31 162 67
2023/20241.056 109 34 59 43 93 243 155 51 23 33 7 206
2024/20252.574 166 1.251 561 307 122 167 0 0 0 0 0 0
Totale 65.325